文献速递类风湿关节炎

北美原住民易感血清阳性类风湿关节炎的分子基础

Molecular basis for increased susceptibility of Indigenous North Americans to seropositive rheumatoid arthritis.
PubMed 文献 · Ann Rheum Dis · 2017-08-11

研究比较344例北美原住民RA患者与352例对照的HLA基因型,并通过晶体结构及T细胞分析,发现HLA-DRB1*14:02因His13βSer多态性改变P4口袋,能同时呈递瓜氨酸化和精氨酸化波形蛋白59-71,扩增自身反应性CD4+ T细胞,从而增加ACPA阳性RA风险。

要点

  • HLA-DRB1*14:02与北美原住民ACPA阳性RA独立相关。
  • 该等位基因His13βSer多态性使P4口袋可容纳瓜氨酸和精氨酸。
  • 患者及高危亲属中可检测到针对两种肽段的寡克隆自身反应性CD4+ T细胞。

核心结论

  • HLA-DRB1*14:02通过拓宽瓜氨酸化及天然自身肽的呈递能力并扩增T细胞,增加ACPA阳性RA风险。

研究设计与样本

  • 比较344例北美原住民RA患者与352例对照的HLA基因型,并用X射线晶体学解析HLA-DRB1*1402-Ⅱ类分子与三种肽段的结构,用四聚体流式细胞术及TCR测序分析抗原特异性CD4+ T细胞。

主要发现

  • 北美原住民中ACPA阳性RA与HLA-DRB1*14:02独立相关。
  • HLA-DRB1*14:02因His13βSer多态性和P4口袋改变,能以相反方向容纳瓜氨酸和精氨酸。
  • 在HLA-DRB1*14:02阳性RA患者及ACPA阴性一级亲属中观察到针对波形蛋白59-71瓜氨酸和精氨酸两种形式的寡克隆自身反应性CD4+效应T细胞。
  • HLA-DRB1*14:02-波形蛋白59-71特异性和HLA-DRB1*14:02-波形蛋白-64Cit59-71特异性CD4+记忆T细胞是表型不同的群体。

临床怎么用

  • 对北美原住民ACPA阳性RA高危个体,可考虑HLA-DRB1*14:02检测以辅助风险评估。
  • HLA-DRB1*14:02阳性者中针对瓜氨酸化和天然波形蛋白的自身反应性T细胞可能成为监测或干预靶点。

局限性

  • 研究限于北美原住民人群,结论外推至其他人群需谨慎。
  • 原文未报告T细胞分析的具体样本量及统计效能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The pathogenetic mechanisms by which HLA-DRB1 alleles are associated with anticitrullinated peptide antibody (ACPA)-positive rheumatoid arthritis (RA) are incompletely understood. RA high-risk HLA-DRB1 alleles are known to share a common motif, the 'shared susceptibility epitope (SE)'. Here, the electropositive P4 pocket of HLA-DRB1 accommodates self-peptide residues containing citrulline but not arginine. HLA-DRB1 His/Phe13β stratifies with ACPA-positive RA, while His13βSer polymorphisms stratify with ACPA-negative RA and RA protection. Indigenous North American (INA) populations have high risk of early-onset ACPA-positive RA, whereby HLA-DRB1*04:04 and HLA-DRB1*14:02 are implicated as risk factors for RA in INA. However, HLA-DRB1*14:02 has a His13βSer polymorphism. Therefore, we aimed to verify this association and determine its molecular mechanism. METHODS: HLA genotype was compared in 344 INA patients with RA and 352 controls. Structures of HLA-DRB1*1402-class II loaded with vimentin-64Arg59-71, vimentin-64Cit59-71 and fibrinogen β-74Cit69-81 were solved using X-ray crystallography. Vimentin-64Cit59-71-specific and vimentin59-71-specific CD4+ T cells were characterised by flow cytometry using peptide-histocompatibility leukocyte antigen (pHLA) tetramers. After sorting of antigen-specific T cells, TCRα and β-chains were analysed using multiplex, nested PCR and sequencing. RESULTS: ACPA+ RA in INA was independently associated with HLA-DRB1*14:02. Consequent to the His13βSer polymorphism and altered P4 pocket of HLA-DRB1*14:02, both citrulline and arginine were accommodated in opposite orientations. Oligoclonal autoreactive CD4+ effector T cells reactive with both citrulline and arginine forms of vimentin59-71 were observed in patients with HLA-DRB1*14:02+ RA and at-risk ACPA- first-degree relatives. HLA-DRB1*14:02-vimentin59-71-specific and HLA-DRB1*14:02-vimentin-64Cit59-71-specific CD4+ memory T cells were phenotypically distinct populations. CONCLUSION: HLA-DRB1*14:02 broadens the capacity for citrullinated and native self-peptide presentation and T cell expansion, increasing risk of ACPA+ RA.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Scally SW, Law SC, Ting YT, et al. Molecular basis for increased susceptibility of Indigenous North Americans to seropositive rheumatoid arthritis. Ann Rheum Dis. 2017. PMID: 28801345. doi:10.1136/annrheumdis-2017-211300

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。